| Bioactivity | Onercept is a recombinant soluble human tumor necrosis factor-alpha p55 receptor for use in Crohn's disease research[1]. |
| Name | Onercept |
| CAS | 199685-57-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul Rutgeerts, et al. Onercept for moderate-to-severe Crohn's disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006 Jul;4(7):888-93. |